How much funding has Immucor raised?

Immucor has raised $2.0B in total funding, most recently a private equity round.

Who are Immucor's investors?

Immucor's investors include Werfen, TPG (Growth/Rise).

Where is Immucor headquartered?

Immucor is headquartered in Norcross, Georgia, United States.

What industry is Immucor in?

Immucor operates in Biotech, Healthcare.

How many employees does Immucor have?

Immucor has 5001-10000 employees.

Immucor

Acquired

Werfen | Leading Provider Of Transfusion & Transplantation Diagnostic Products Worldwide

Norcross, United States · Founded 1982 · $2.0B raised

Biotech

Healthcare

Headquarters: Norcross, Georgia
Employees: 5001–10000
Founded: 1982
Business Model: B2B

Website: transfusionandtransplant.werfen.com
Total Funding: $2.0B
Last Round: $2.0B Private EquityJul 2011
Rounds: 1

About

Global leader in transfusion and transplantation diagnostics providing products and solutions to ensure donor-recipient compatibility. Serves hospitals, clinical laboratories, and donor centers worldwide with serology, molecular products, and coagulation diagnostics.

Summary

Immucor is a Biotech company based in Norcross, United States, founded in 1982. It has raised $2.0B in total across 1 round, most recently a $2.0B Private Equity round in Jul 2011. Investors include Werfen and TPG (Growth/Rise).

LinkedIn X (Twitter)